Using the KPC mouse model of PDAC, which is not responsive to immunotherapy, Jiang et al. tested the effects of FAK inhibition alone or in combination with ICIs on tumor progression, fibrosis, and immune cell infiltration. The gene discussed is PTK2; the disease is neoplasm.